Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT®, Its Disruptive, Non-Invasive, Ultrasound Treatment

The trial with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasibleprovide a sustained repair of the aortic valveimprove quality of life...

Study shows improved AF detection using MCOT patch and implantable loop recorder

Royal Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first-line diagnostic ambulatory monitoring solution with post-cryptogenic stroke patients. The study...

Cardiovascular Systems, Inc. Announces First In-Human Experience With Peripheral Everolimus Drug-Coated Balloon

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery...

AI programme yields promising results for chest x-rays diagnosing COVID-19

An Artificial Intelligence (AI) programme created by Bering Limited and study conducted by iCAIRD, Scotland’s Industrial Centre for AI Research in Digital Diagnostics has...

GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and Localize Fractures

GLEAMER, a French MedTech company pioneering the use of artificial intelligence technology in the practice of radiology, announced that the United States Food and...

Biosensor aiming to cut opioid overdose deaths undergoes clinical trial

Dundee University is commencing the clinical trial of PneumoWave’s wearable device that aims to reduce the growing number of fatal opioid overdoses in Scotland. John...

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical...

Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial

Study will advance the validation of Cellvizio® as a real-time biopsy guidance tool during robotic-assisted bronchoscopy that may reduce the near-miss rate of peripheral...

Nevro announces publication of 12-month data on high-frequency SCS for non-surgical refractory back pain

Nevro Corporation has announced online publication of 12-month data from the SENZA-NSRBP randomised controlled trial (RCT) in Journal of Neurosurgery: Spine. These data show that...

Latest articles